Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 15, 2019 | Director, Chairman & CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 103,500 | $11.71 | 668,081 | |
| Jan 15, 2019 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 103,500 | -- | -- | |
| Jan 15, 2019 | Chief Science Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 4,400 | $2.94 | 452,713 | |
| Jan 15, 2019 | Chief Science Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 3,800 | $5.13 | 456,513 | |
| Jan 15, 2019 | Chief Science Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 16,600 | $12.00 | 439,913 | |
| Jan 15, 2019 | Chief Science Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 4,400 | -- | 4,988 | |
| Jan 15, 2019 | Chief Science Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 3,800 | -- | 66,821 | |
| Jan 10, 2019 | Chief Medical Officer | Other acquisition or disposition | Form 4 | -- | -- | 125 | |
| Jan 10, 2019 | Director, Chairman & CEO | Other acquisition or disposition | Form 4 | -- | -- | 64,895 | |
| Jan 10, 2019 | Chief Legal Officer | Other acquisition or disposition | Form 4 | -- | -- | 15,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.